Mathias Lidgren
Director/Board Member at REX INTERNATIONAL HOLDING LIMITED
Net worth: 657 720 $ as of 31/05/2024
Profile
Mathias Lidgren is currently a Non-Independent Non-Executive Director at Rex International Holding Ltd.
He is also a Director at Captiosus AB, Rotationsplast i Munka-Ljungby AB, Caithness Fastighets AB, Forvaltningsaktiebolaget Maple, Trolleholms Slott AB, Strominnate Therapeutics AB, Moroxite T AB, and Moroxite Holding Pte Ltd.
In terms of education, Dr. Lidgren holds a doctorate degree from Karolinska Institutet, a graduate degree from the University of Cambridge, and an undergraduate degree from the International University of Monaco.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/03/2024 | 7,000,000 ( 0.53% ) | 657 720 $ | 31/05/2024 |
Mathias Lidgren active positions
| Companies | Position | Start |
|---|---|---|
| REX INTERNATIONAL HOLDING LIMITED | Director/Board Member | 04/05/2022 |
Rotationsplast i Munka-Ljungby AB
 Rotationsplast i Munka-Ljungby AB Miscellaneous ManufacturingProducer Manufacturing Rotationsplast i Munka-Ljungby AB is a private company that manufactures polyethylene products. The company is based in Munka-Ljungby, Sweden. | Director/Board Member | - |
| Caithness Fastighets AB | Director/Board Member | - |
| Forvaltningsaktiebolaget Maple | Director/Board Member | - |
| Trolleholms Slott AB | Director/Board Member | - |
| Captiosus AB | Director/Board Member | - |
Strominnate Therapeutics AB
 Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Director/Board Member | - |
Moroxite Holding Pte Ltd.
 Moroxite Holding Pte Ltd. Financial ConglomeratesFinance Part of Rex International Holding Ltd., Moroxite Holding Pte Ltd. functions as an investment holding Singaporean company. The company is based in Singapore, Singapore. | Director/Board Member | - |
Moroxite T AB
 Moroxite T AB Medical SpecialtiesHealth Technology Part of Rex International Holding Ltd., Moroxite T AB is a Swedish medical-technology company that develops devices for tumor. The company is based in Lund, Sweden. Moroxite T was acquired by Moroxite Holding Pte Ltd. from Moroxite AB on July 31, 2023 for $4.13 million. | Chief Tech/Sci/R&D Officer | - |
Training of Mathias Lidgren
| Karolinska Institutet | Doctorate Degree |
| University of Cambridge | Graduate Degree |
| International University of Monaco | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REX INTERNATIONAL HOLDING LIMITED | Energy Minerals |
| Private companies | 8 |
|---|---|
| Captiosus AB | |
Rotationsplast i Munka-Ljungby AB
Rotationsplast i Munka-Ljungby AB Miscellaneous ManufacturingProducer Manufacturing Rotationsplast i Munka-Ljungby AB is a private company that manufactures polyethylene products. The company is based in Munka-Ljungby, Sweden. | Producer Manufacturing |
| Caithness Fastighets AB | |
| Forvaltningsaktiebolaget Maple | |
| Trolleholms Slott AB | |
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Commercial Services |
Moroxite T AB
Moroxite T AB Medical SpecialtiesHealth Technology Part of Rex International Holding Ltd., Moroxite T AB is a Swedish medical-technology company that develops devices for tumor. The company is based in Lund, Sweden. Moroxite T was acquired by Moroxite Holding Pte Ltd. from Moroxite AB on July 31, 2023 for $4.13 million. | Health Technology |
Moroxite Holding Pte Ltd.
Moroxite Holding Pte Ltd. Financial ConglomeratesFinance Part of Rex International Holding Ltd., Moroxite Holding Pte Ltd. functions as an investment holding Singaporean company. The company is based in Singapore, Singapore. | Finance |
- Stock Market
- Insiders
- Mathias Lidgren
